SE9800729L - Ny topikal formulering I - Google Patents

Ny topikal formulering I

Info

Publication number
SE9800729L
SE9800729L SE9800729A SE9800729A SE9800729L SE 9800729 L SE9800729 L SE 9800729L SE 9800729 A SE9800729 A SE 9800729A SE 9800729 A SE9800729 A SE 9800729A SE 9800729 L SE9800729 L SE 9800729L
Authority
SE
Sweden
Prior art keywords
topical formulation
new topical
emulsifier
new
carrier
Prior art date
Application number
SE9800729A
Other languages
English (en)
Swedish (sv)
Other versions
SE9800729D0 (sv
Inventor
Anders Carlsson
Jenny Ek
Bengt Hersloef
Goeran Nilsson
Original Assignee
Scotia Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20410443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9800729(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Lipidteknik Ab filed Critical Scotia Lipidteknik Ab
Priority to SE9800729A priority Critical patent/SE9800729L/xx
Publication of SE9800729D0 publication Critical patent/SE9800729D0/xx
Priority to JP2000534188A priority patent/JP2002505272A/ja
Priority to DE69912760T priority patent/DE69912760T2/de
Priority to CA002322850A priority patent/CA2322850A1/fr
Priority to AU31778/99A priority patent/AU750526B2/en
Priority to DK99913784T priority patent/DK1069886T3/da
Priority to NZ506756A priority patent/NZ506756A/en
Priority to EP99913784A priority patent/EP1069886B1/fr
Priority to AT99913784T priority patent/ATE253895T1/de
Priority to PT99913784T priority patent/PT1069886E/pt
Priority to ES99913784T priority patent/ES2211062T3/es
Priority to PCT/SE1999/000347 priority patent/WO1999044585A1/fr
Publication of SE9800729L publication Critical patent/SE9800729L/xx
Priority to US10/976,127 priority patent/US20050063930A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9800729A 1998-03-06 1998-03-06 Ny topikal formulering I SE9800729L (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I
PCT/SE1999/000347 WO1999044585A1 (fr) 1998-03-06 1999-03-08 Formulation de produit en application locale du type emulsion huile dans l'eau, comprenant comme emulsifiant un galactolipide, et permettant l'effet prolonge d'une substance incorporee
ES99913784T ES2211062T3 (es) 1998-03-06 1999-03-08 Utilizacion de una formulacion topica del tipo de emulsion de aceite en agua, que comprende como emulsionante un material galactolipidico, para proporcionar un efecto prolongado de una sustancia activa incorporada.
DK99913784T DK1069886T3 (da) 1998-03-06 1999-03-08 Anvendelse af en topisk formulering af typen olie-i-vand omfattende galactolipidmateriale som emulgator til tilvejebringelse af en forlænget virkning af et inkorporeret aktivt stof
DE69912760T DE69912760T2 (de) 1998-03-06 1999-03-08 Verwendung von topischen formulierungen des öl-in-wasser typs, enthaltend galaktolipid material als emulsionsmittel, um eine länger anhaltende wirkung eines darin enthaltenen aktiven wirkstoffs zu vermitteln
CA002322850A CA2322850A1 (fr) 1998-03-06 1999-03-08 Formulation de produit en application locale du type emulsion huile dans l'eau, comprenant comme emulsifiant un galactolipide, et permettant l'effet prolonge d'une substance incorporee
AU31778/99A AU750526B2 (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
JP2000534188A JP2002505272A (ja) 1998-03-06 1999-03-08 乳化剤としてガラクト脂質物質からなり、導入された活性物質の持続作用を有する水中油型局所用組成物
NZ506756A NZ506756A (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
EP99913784A EP1069886B1 (fr) 1998-03-06 1999-03-08 Usage d'une formulation de produit en application locale du type emulsion huile dans l'eau, comprenant comme emulsifiant un galactolipide, pour obtenir l'effet prolonge d'une substance incorporee
AT99913784T ATE253895T1 (de) 1998-03-06 1999-03-08 Verwendung von topischen formulierungen des öl-in-wasser typs, enthaltend galaktolipid material als emulsionsmittel, um eine länger anhaltende wirkung eines darin enthaltenen aktiven wirkstoffs zu vermitteln
PT99913784T PT1069886E (pt) 1998-03-06 1999-03-08 Formulacoes topica do tipo oleo-em-agua compreendendo um material galactolipidico como emulsionante com um efeito prolongado de uma substancia activa incorporada
US10/976,127 US20050063930A1 (en) 1998-03-06 2004-10-29 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I

Publications (2)

Publication Number Publication Date
SE9800729D0 SE9800729D0 (sv) 1998-03-06
SE9800729L true SE9800729L (sv) 1999-09-07

Family

ID=20410443

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I

Country Status (12)

Country Link
EP (1) EP1069886B1 (fr)
JP (1) JP2002505272A (fr)
AT (1) ATE253895T1 (fr)
AU (1) AU750526B2 (fr)
CA (1) CA2322850A1 (fr)
DE (1) DE69912760T2 (fr)
DK (1) DK1069886T3 (fr)
ES (1) ES2211062T3 (fr)
NZ (1) NZ506756A (fr)
PT (1) PT1069886E (fr)
SE (1) SE9800729L (fr)
WO (1) WO1999044585A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304906A1 (fr) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, un regulateur de biocompatibilite vasculaire et un inhibiteur d'hyperplasie cellulaire
EP1151745A1 (fr) * 2000-05-05 2001-11-07 L'oreal Composition sous forme d'émulsion eau-dans-huile et ses utilisations cosmétiques
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
WO2004002420A2 (fr) 2002-06-28 2004-01-08 Nitromed, Inc. Inhibiteurs a selectivite cyclooxygenase-2 nitrosiles et/ou nitroses contenant une oxime et/ou une hydrazone, compositions et methodes d'utilisation correspondantes
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
ES2429040T5 (es) * 2004-08-31 2017-06-13 Stiefel Research Australia Pty Ltd Método y composiciones de microemulsión y emulsión submicrónica
BRPI0608444A2 (pt) * 2005-03-04 2009-12-29 Dsm Ip Assets Bv composição lipìdica particulada alimentìcia
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
AU2006291588A1 (en) * 2005-09-16 2007-03-22 Dsm Ip Assets B.V. Particulate lipid pharmaceutical composition
TWI630207B (zh) 2005-12-13 2018-07-21 英塞特控股公司 作為傑納斯激酶（ＪＡＮＵＳ ＫＩＮＡＳＥ）抑制劑之經雜芳基取代之吡咯并〔２，３-ｂ〕吡啶及吡咯并〔２，３-ｂ〕嘧啶
WO2008084253A1 (fr) * 2007-01-12 2008-07-17 Lipopeptide Ab Utilisation d'un galactolipide pour cicatrisation de plaies et d'ulcères
JP2010524860A (ja) * 2007-04-20 2010-07-22 ユニバーシティー オブ サウス オーストラリア 薬剤の皮膚送達用ナノ粒子コーティングカプセル製剤
RS63043B1 (sr) 2009-11-03 2022-04-29 Lipidor Ab Kompozicija koja obrazuje lipidni sloj za primenu na površinu živog organizma
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
SG10201912203XA (en) 2013-08-07 2020-02-27 Incyte Corp Sustained release dosage forms for a jak1 inhibitor
JP2017529334A (ja) * 2014-08-27 2017-10-05 アッヴィ・インコーポレイテッド 局所製剤
PL3297605T3 (pl) 2015-05-21 2022-07-11 Dermavant Sciences GmbH Kompozycje farmaceutyczne do stosowania miejscowego
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
LT3310389T (lt) 2015-06-18 2020-11-10 Bausch Health Ireland Limited Vietinio vartojimo kompozicijos, apimančios kortikosteroidą ir retinoidą, skirtos psoriazės gydymui
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597118A (ja) * 1982-06-16 1984-01-14 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 化粧用組成物
JPS649908A (en) * 1987-07-02 1989-01-13 Kao Corp Cosmetic, cosmetic set and make-up method
JPH0374316A (ja) * 1989-08-11 1991-03-28 Kanebo Ltd 保湿剤
JPH0818948B2 (ja) * 1990-08-31 1996-02-28 花王株式会社 水性化粧料及びその製造法
JPH0543465A (ja) * 1991-08-08 1993-02-23 Mitsubishi Kasei Corp コルチコステロイド含有ローシヨン剤
JPH069365A (ja) * 1992-06-25 1994-01-18 Kanebo Ltd 皮膚化粧料
SK282537B6 (sk) * 1993-03-12 2002-10-08 Axys Pharmaceuticals, Inc. Inhibítor tryptázy alebo jeho farmaceuticky prijateľná soľ, farmaceutický prostriedok s jeho obsahom a jeho použitie
FR2710854B1 (fr) * 1993-10-08 1995-12-01 Oreal Emulsion huile-dans-eau utilisable pour l'obtention d'une crème.
CA2182575C (fr) * 1994-02-04 2000-11-28 Anders Carlsson Emulsions huile dans l'eau
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
SE504664C2 (sv) * 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan
JP3326059B2 (ja) * 1995-10-05 2002-09-17 カネボウ株式会社 皮膚化粧料

Also Published As

Publication number Publication date
ATE253895T1 (de) 2003-11-15
PT1069886E (pt) 2004-04-30
DE69912760T2 (de) 2004-09-30
NZ506756A (en) 2003-10-31
AU3177899A (en) 1999-09-20
ES2211062T3 (es) 2004-07-01
JP2002505272A (ja) 2002-02-19
CA2322850A1 (fr) 1999-09-10
DK1069886T3 (da) 2004-03-22
DE69912760D1 (de) 2003-12-18
EP1069886A1 (fr) 2001-01-24
SE9800729D0 (sv) 1998-03-06
EP1069886B1 (fr) 2003-11-12
WO1999044585A1 (fr) 1999-09-10
AU750526B2 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
SE9800729L (sv) Ny topikal formulering I
DK0892638T3 (da) Liposombaseret, topisk vitamin D-præparat
ATE286718T1 (de) Temperatursensitive liposomale formulierung
BR0314354A (pt) Formação para gentes lipofìlicos
NO995367D0 (no) Aktivert Vitamin D3-emulsjonstype lotioner
CO4940390A1 (es) Composicion liquida de limpieza antimicrobiana que comprende un activo antimicrobiano, un surfactante, agentes y un esta- bilizador
BR0009893A (pt) Composição de cuidado com a pele; e uso de uma composição de cuidado com a pele
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
ATE269047T1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
BR0108738A (pt) Formulações anestésicas
DE69635987D1 (de) Verbesserte liposomale formulierung
BR9806268A (pt) Composições contendo um antifúngico e um fosfolipìdeo
BR0013968B1 (pt) composicão estruturante de produto para formulações de cuidados pessoais.
SE9800730L (sv) Ny topikal formulering II
TR199903271T2 (en) Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.
DE59800863D1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
EP1269978A3 (fr) Utilisation de dérivés de la bis-resorcinyl triazine dans des préparations cosmétiques ou dermatologiques
DK0647129T3 (da) Præparat til topisk anvendelse
ATE230251T1 (de) Lipidmembran zusammensetzungen
DE59900473D1 (de) Wirkstoffkombinationen aus vitamin a- derivate und ubi- oder plastochinonen enthaltende hautpflegmittel
DE69916266D1 (de) Prostaglandine und benzylalcohol enthaltende lösung
DE69906116D1 (de) Vitaminzusammensetzung zur topischen anwendung
UY26510A1 (es) " biblioteca de sustancias, procedimiento para su preparación y el uso de esta biblioteca de sustancias para la investigación de sustancias activas."
ATE301453T1 (de) Injizierbare arzneiformulierungen von partricin derivaten

Legal Events

Date Code Title Description
NAV Patent application has lapsed